The role of positron emission tomography scan with 18F-fluorodeoxyglucose (FDG-PET) as the chief predictor of autologous stem cell transplantation in aggressive B-cell non-Hodgkin lymphoma.

被引：0
|
作者：
Caroli, P. [1 ]
Fantini, L. [1 ]
Ambrosini, V. [1 ]
Lopci, E. [1 ]
Musto, A. [1 ]
Maffione, A. [1 ]
Golemi, A. [1 ]
Santi, I. [1 ]
Fuccio, C. [1 ]
Tsamita, C. [1 ]
Derenzini, E. [1 ]
Zinzani, P. [1 ]
Fanti, S. [1 ]
机构：
[1] Azienda Osped Univ Bologna, S Orsola Malpighi Univ Hosp, Bologna, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2009年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S335 / S336
页数：2
相关论文
共 50 条
  • [41] Interim 18f[FDG] Positron Emission Tomography in Patients with Diffuse Large B-Cell Lymphoma.
    Gigli, Federica
    Nassi, Luca
    Negri, Mara
    Travaini, Laura
    Steffanoni, Sara
    Liptrott, Sarah Jane
    Mancuso, Patrizia
    Bertazzoni, Paola
    Bassi, Simona
    Calabrese, Liliana
    Cocorocchio, Emilia
    Martinelli, Giovanni
    BLOOD, 2008, 112 (11) : 1234 - 1234
  • [42] Effect of steroid treatment on the diagnostic yield of baseline 18f-fluorodeoxyglucose positron emission tomography in aggressive B cell lymphoma
    Karyn Revital Geiger
    Oren Pasvolsky
    Tamar Berger
    Pia Raanani
    Tzippy Shochat
    Ronit Gurion
    Tamer Anati
    David Groshar
    Anat Gafter-Gvili
    Hanna Bernstine
    EJNMMI Research, 12
  • [43] Effect of steroid treatment on the diagnostic yield of baseline 18f-fluorodeoxyglucose positron emission tomography in aggressive B cell lymphoma
    Geiger, Karyn Revital
    Pasvolsky, Oren
    Berger, Tamar
    Raanani, Pia
    Shochat, Tzippy
    Gurion, Ronit
    Anati, Tamer
    Groshar, David
    Gafter-Gvili, Anat
    Bernstine, Hanna
    EJNMMI RESEARCH, 2022, 12 (01)
  • [44] F-18FDG positron emission tomography in non-Hodgkin lymphoma of the breast
    Kumar, R
    Xiu, Y
    Dhurairaj, T
    Yu, XQ
    Alavi, A
    Zhuang, HM
    CLINICAL NUCLEAR MEDICINE, 2005, 30 (04) : 246 - 248
  • [45] Application of 18F-fluorodeoxyglucose positron emission tomography/computerized tomography in mantle cell lymphoma
    Yang Shaoxi
    Fu Lilan
    AbuduRxiti, Meilinur
    Wu Jianhua
    Wang Qiaoyu
    Qin Yongde
    Zou Xiaoguang
    Li Hongsheng
    NUCLEAR MEDICINE COMMUNICATIONS, 2020, 41 (05) : 477 - 484
  • [46] Clinical role of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in the detection and management of renal cell carcinoma.
    Ramdave, S
    Thomas, G
    Berlangieri, SU
    Bolton, DM
    Davis, ID
    Tochon-Danguy, H
    Macgregor, D
    Scott, AM
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 80P - 80P
  • [47] 18F-fluorodeoxyglucose positron emission tomography in the staging and prognosis of T cell lymphoma
    Casulo, Carla
    Schoeder, Heiko
    Feeney, John
    Lim, Remy
    Maragulia, Jocelyn
    Zelenetz, Andrew D.
    Horwitz, Steven
    LEUKEMIA & LYMPHOMA, 2013, 54 (10) : 2163 - 2167
  • [48] The usefulness of the intensity of 18fluorodeoxyglucose uptake in positron emission tomography (FDG-PET) in distinguishing between indolent and aggressive non-Hodgkin's lymphomas
    Sobrevilla-Calvo, P.
    Chalapud, J.
    Rivas-Vera, S.
    Altamirano-Ley, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [49] Prognosis value of positron emission tomography using F18-fluorodeoxyglucose (FDG-PET) in the setting of ASCT in patients with high grade non-Hodgkin lymphoma (HGNHL).
    Bodet-Milin, C.
    Rolland, V.
    Oudoux, A.
    Aansquer, C.
    Le Goille, S.
    Valette, F.
    Rousseau, C.
    Dupas, B.
    Moreau, P.
    Harrousseau, J.
    Kraeber-Bodere, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S85 - S85
  • [50] 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) does not visualize follicular lymphoma of the duodenum
    Martha Hoffmann
    Andreas Chott
    Andreas Püspök
    Ulrich Jäger
    Kurt Kletter
    Markus Raderer
    Annals of Hematology, 2004, 83 : 276 - 278
12345